Liquidia Technologies is trading at $74.53 (4.1% down) as the stock pulls back from recent all-time highs amid technical overbought signals and a broader sector downturn.

  • Shares reached record levels during a sharp multi-day rally, but RSI readings now suggest the stock is overextended after trading near 52-week highs.
  • Investors are weighing significant short-term gains against persistent litigation risks involving YUTREPIA, leading to profit-taking as growth and biotech stocks sell off.